| TGA Action ID |
RC-2026-RN-00803-1 |
| Type of Product |
Medicine |
| Product Name/Description |
Thompson's Immunofort 60 and 120 Tablets
All batches within expiry |
| ARTG Number |
405616 |
| Action Type |
Recall |
| Action Level |
Consumer |
| Hazard Classification |
Class I |
| Reason for the Action |
Since 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis.
However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines.
Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no longer available for use in new listed (low risk) medicines for supply in Australia. |
| Instructions for Customers/Users |
Distributors/retailers are to:
· Inspect their stock immediately and quarantine all stock of Thompson’s Immunofort on hand to prevent further use or distribution.
· Return or dispose of affected stock on hand following the instructions in the customer letter.
· Retailers are recommended to place the ‘Public Notice’ attached to this letter in their storefront to alert consumers about the recall.
Consumers:
· Consumers are advised that if they have the above product, to not use it.
· Consumers can return the product to the place of purchase, or contact Homart Wellness at TeamQA@homart.com.au to arrange the return of product for a refund.
· If someone is suspected of having anaphylaxis, call for emergency medical help immediately by dialling ‘000’. |
| Action Commencement Date |
19/10/2026 |
| Responsible Entity |
|
| Contact Information |
02 9648 2880 - Elmer Zarate, Homart Wellness |